Cardio Flashcards

1
Q

What is HTN a major contributing factor in?

A
Coronary artery dz
Stroke
CHF
Chronic renal failure
Atherosclerosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Nl BP

A

<120/<80

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Prehypertension

A

120-139/80-89

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Stage 1 HTN

A

140-159/90-99

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Stage 2 HTN

A

160-179/100-109

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Blood pressure formula

A

CO x SVR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the primary factors determining blood pressure?

A

Sympathetic nervous system
Renin-angiotensin-aldosterone system
Plasma volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the cause of the majority of HTN?

A

Idiopathic (primary)

Numerous genetic and environmental factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When should one have clinical suspicion of secondary HTN?

A

Onset <30 or >50
Sudden onset of HTN
Sudden change in chronic HTN
Multi-drug resistant HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Risk factors for primary HTN

A
Increasing age
Obesity
FHx
Physical inactivity
Ethnicity
EtOH
Smoking
DM
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Secondary causes of HTN

A
Renal
-Acute and chronic kidney dz
Adrenal
-Cushing's syndrome
Pheochromocytoma (intermittent sx)
Hyperaldosteronism (hypokalemia, HTN, metabolic alkalosis)
OCPs
Decongestants
NSAIDs
MAOIs
Cocaine
Wt loss meds
Stimulants
Hyperthyroid
Hyperparathyroid
Pregnancy
Coarctation of the aorta
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

End organ damage in HTN

A
Claudication
Bruits
LVH
Retinopathy
Renal disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Labs for HTN

A
CBC
CMP
BUN/creatinine
FBS/Hgb A1c
Lipid panel
TSH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Additional testing for HTN

A
CXR
ECG
Ambulatory BP monitoring
Echo
Labs for secondary causes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

HTN eval

A

Pt seated for 5 minutes, feet flat on the floor, arm supported at heart level
Appropriate sized cuff
At least two readings…both arms
1/2 hr after eating, drinking, smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

MOA of ACE inhibitors

A

Prevent conversion of angiotensin I to angiotensin II

Prevention of breadkdown of bradykinin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

MOA of dihydropyridine calcium channel blockers

A

Work more in the peripheral vasculature, cause vasodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Contraindications of ACE/ARB

A

Pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

MOA of nondihyrdopyridine CCBs

A

Work centrally on the heart
Have inotropic and chronotropic effects
Increase HR and contractility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Contraindication of dihydropyridine calcium channel blockers

A

Heart failure

Be careful using nondihyrdopyridines with BBs, specifically cardioselective because of decrease in HR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Examples of thiazide diuretics

A

Chlorthiadone
Indapamide
Hydrochlorothiazide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Examples of loop diuretics

A

Bumetanide
Furosemide
Torsemide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Examples of aldosterone antagonists

A

Spironolactone

Eplerenone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Examples of potassium sparing diuretics

A

Amilioride

Triamterene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

When to use aldosterone antagonists for HTN

A

Esp spironolactone

Used in resistant HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Which diuretics are not affected by renal function?

A

Loops

27
Q

Which beta blockers are considered cardioselective?

A

Metoprolol
Atenolol
Bisoprolol

28
Q

Recommendations for HTN med dosing

A

Titrate to max dose, then add a second drug

29
Q

What is treating resistant HTN predicted on?

A

Lifestyle factors
Appropriate tx of secondary outcomes
Effective multi-drug regimens

30
Q

Med regimens for resistant HTN

A

Diuretic therapy
Combo therapy
Mineralcorticoid receptor antagonists
Beta blockers, central alpha 2 agonists, direct vasodilators

31
Q

What med regimen should be in place before diagnosing resistant HTN?

A

Thiazide
CCB
ACE/ARB

32
Q

What is the difference in ejection fraction between systolic and diastolic heart failure?

A

Systolic ~33%
Diastolic ~57%
Nl ~66%

33
Q

Causes of systolic heart failure

A
Reduction in muscle mass (MI)
Dilated cardiomyopathies
Ventricular hypertrophy
-Pressure overload
--Pulmonary HTN
--Aortic/pulmonic valve stenosis
-Volume overload
--Valvular regurgitation
--Shunts
--High-output states
34
Q

Causes of diastolic heart failure

A
Increase ventricular stiffness
Ventricular hypertrophy
-HCM
Infiltrative myocardial disease
-Amyloidosis
-Sarcoidosis
-Endomyocardial fibrosis
Myocardial ischemia and infarction
Mitral/tricuspid stenosis
Pericardial disease
-Pericarditis
-Pericardial tamponade
35
Q

Tx of stage A heart failure

A
Stage A: not symptomatic and NO current evidence of structural heart dz, pts at high risk for heart failure
Aggressive risk factor control:
-Control HTN per current guideline recs
-Smoking cessation
-Control dyslipidemia per current guidelines
-Increased physical activity
-Encourage wieght loss if obeses
-Control diabetes per current guidelines
-Discourage EtOH and illicit drug use
36
Q

What is stage B heart failure?

A

Pts with structural heart disease but are asymptomatic

37
Q

Tx of stage B heart failure

A
All txs for stage A
ACE inhibitor or ARB
-Pts s/p ACS/MI or reduced EF
BB select medications
-Pts s/p ACS/MI or reduced EF
38
Q

What 3 BBs are utilized in heart failure?

A

Carvedilol
Bisoprolol
Metoprolol succinate

39
Q

MOA of BBs

A

Inhibitor/block beta receptors
Net effect:
-Decreased sensitivity to circulating catecholamines
-Decreased HR/BP

40
Q

When should BBs be initiated in heart failure?

A

Only initiate beta blocker when heart failure is stable and pt is euvolemic

41
Q

What is the net effect of ACE inhibitors?

A

Arterial and venous vasodilation

Reduction of preload and afterload (reduced workload on heart)

42
Q

Absolute contraindications of ACE inhibitors

A

Hx of angioedema secondary to ACE inhibitor
Pregnancy (category X)
Bilateral renal artery stenosis

43
Q

MOA of ARBs

A

Block the AT1 receptor to stop the actions of angiotensin II
-Decreased vasoconstriction, aldosterone release, cellular growth promotion
Net effect:
-Arterial and venous vasodilation
-Reduction of preload and afterload (reduced workload on heart)

44
Q

Stage C tx for diastolic heart failure

A

Diuresis to relieve sx of congestion

Follow guideline driven indications for comorbidities

45
Q

Stage C tx for systolic heart failure

A
All txs for stage A
ACEI or ARB
BB (select medications)
Diuretics
Devices
-Biventricular pacing
-Implantable defibrillators
46
Q

MOA of diuretics

A

Block Na resorption at the thick ascending loop of Henle

47
Q

MOA of aldosterone antagonists

A

Inhibits aldosterone
-Increased levels of aldosterone in HF to increase Na/H2O retention and improve CO
Weak diuretic effect

48
Q

Stage D heart failure tx

A
All txs for stage A-C
Heart transplant
Chronic inotropic meds
Mechanical support
Palliative care/hospice
49
Q

MOA of sacubitril/valsartin

A

Valsartan: ARB
Sacubitril: inhibits neprilysin
-Net effect: Increase natriuretic peptides that decrease blood volume and preload

50
Q

Causes of HF exacerbation

A
Acute coronary syndromes
Med nonadherence
Na/fluid restriction nonadherence
Uncontrolled BP
A fib
Addition of drugs that worsen HF
Pulmonary embolus
Infection
Excessive alcohol use
51
Q

S/sx of hypoperfusion in HF exacerbation

A

Cool extremities
Sleepy
Declining Na levels

52
Q

S/sx of congestion in HF exacerbation

A
Orthopnea
DOE
High JVP
Pulmonary edema
Peripheral edema
Elevated BNP
Wt gain
53
Q

How to address congestion in HF exacerbation

A

Loop diuretics

+/- vasodilators

54
Q

How to address hypoperfusion in HF exacerbation

A

Positive inotropes

+/- fluid replacement

55
Q

How to address congestion and hypoperfusion in HF exacerbation

A

Mixture of diuretics, vasodilators, inotropes

56
Q

Vasodilators for HR exacerbation

A

Nitroprusside- not seen often
Nitroglycerin
Nesiritide

57
Q

Inotropes utilized for HR exacerbation

A

Dopamine
Dobutamine
Milrinone

58
Q

What are ACEs first line therapy for?

A
Heart failure
Left ventricular dysfunction
In all pts with STEMI
NSTEMI with an anterior MI
Diabetes
Systolic dysfunction
Proteinuric chronic kidney dz
59
Q

Indications for ARBs

A

Similar to ACEs
Specific benefit with severe HTN with EKG evidence of left ventricular hypertrophy
ARB indicated in those who don’t tolerate ACEs

60
Q

Indications for thiazide diuretics

A

Volume control with heart failure or chronic kidney dz

61
Q

Indication for CCB

A

Rate control with atrial fib or control of angina

62
Q

Indications for BB

A

Acute MI
Rate control for A fib
Angina

63
Q

How is orthostatic hypotension evaluated?

A

Evaluated by measuring the individual’s BP and pulse rate while he or she is reclining and again after the individual swiftly moves to a standing position
Test is positive with systolic blood pressure decrease of at least 20 mm Hg or a diastolic blood pressure decrease of at least 10 mm Hg within three minutes of standing

64
Q

Testing for orthostatic hypotension

A
Tilt test
Chemistry panel- hypoglycemia, dehydration
CBC- anemia
Blood/urine cultures- sepsis
12 lead EKG
Echo
Holter/event monitor
UA
CXR/CT